IA

IFP Advisors Portfolio holdings

AUM $3.88B
1-Year Est. Return 17.67%
This Quarter Est. Return
1 Year Est. Return
+17.67%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.88B
AUM Growth
+$361M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
5,247
New
Increased
Reduced
Closed

Top Sells

1 +$23.7M
2 +$11.7M
3 +$11M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$10M
5
ALK icon
Alaska Air
ALK
+$8.98M

Sector Composition

1 Technology 11.75%
2 Financials 4.5%
3 Consumer Discretionary 3.45%
4 Healthcare 3.3%
5 Industrials 3.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMPX icon
5026
Compass Therapeutics
CMPX
$934M
$21 ﹤0.01%
+6
GETY icon
5027
Getty Images
GETY
$636M
$20 ﹤0.01%
+10
ACB
5028
Aurora Cannabis
ACB
$257M
$18 ﹤0.01%
3
-15
APMU icon
5029
ActivePassive Intermediate Municipal Bond ETF
APMU
$200M
$18 ﹤0.01%
1
-364
CHGG icon
5030
Chegg
CHGG
$102M
$18 ﹤0.01%
12
-94
MDWD icon
5031
MediWound
MDWD
$246M
$18 ﹤0.01%
+1
STRO icon
5032
Sutro Biopharma
STRO
$76.7M
$18 ﹤0.01%
21
-57
AVBP icon
5033
ArriVent BioPharma
AVBP
$1.01B
$18 ﹤0.01%
1
CENN icon
5034
Cenntro
CENN
$14.4M
$17 ﹤0.01%
28
+6
MKTW icon
5035
MarketWise
MKTW
$39.2M
0
WKHS icon
5036
Workhorse Group
WKHS
$14M
$17 ﹤0.01%
15
-1
ELA icon
5037
Envela
ELA
$326M
0
LYEL icon
5038
Lyell Immunopharma
LYEL
$665M
$16 ﹤0.01%
1
-65
VTYX icon
5039
Ventyx Biosciences
VTYX
$620M
$16 ﹤0.01%
5
-44
GENVR
5040
Gen Digital Inc Contingent Value Rights
GENVR
$15 ﹤0.01%
2
AMLX icon
5041
Amylyx Pharmaceuticals
AMLX
$1.44B
$14 ﹤0.01%
+1
LVWR icon
5042
LiveWire
LVWR
$930M
$14 ﹤0.01%
3
LYRA icon
5043
Lyra Therapeutics
LYRA
$7.15M
$13 ﹤0.01%
2
-304
BGFV
5044
DELISTED
Big 5 Sporting Goods
BGFV
$12 ﹤0.01%
8
DEHP icon
5045
Dimensional Emerging Markets High Profitability ETF
DEHP
$306M
-32
DLHC icon
5046
DLH Holdings
DLHC
$84.4M
0
NAZ icon
5047
Nuveen Arizona Quality Municipal Income Fund
NAZ
$147M
$12 ﹤0.01%
+1
RWX icon
5048
SPDR Dow Jones International Real Estate ETF
RWX
$290M
-2,088
CTNM
5049
Contineum Therapeutics
CTNM
$365M
$12 ﹤0.01%
1
BIOA
5050
BioAge Labs
BIOA
$455M
$12 ﹤0.01%
+2